(6R,7R)-3-(Acetoxymethyl)-7-(2-(4-chlorophenyl)-acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid

ID: ALA4443633

Chembl Id: CHEMBL4443633

PubChem CID: 68239195

Max Phase: Preclinical

Molecular Formula: C18H17ClN2O6S

Molecular Weight: 424.86

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)OCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3ccc(Cl)cc3)[C@H]2SC1

Standard InChI:  InChI=1S/C18H17ClN2O6S/c1-9(22)27-7-11-8-28-17-14(16(24)21(17)15(11)18(25)26)20-13(23)6-10-2-4-12(19)5-3-10/h2-5,14,17H,6-8H2,1H3,(H,20,23)(H,25,26)/t14-,17-/m1/s1

Standard InChI Key:  PBAXHVPFTLYIOL-RHSMWYFYSA-N

Associated Targets(non-human)

Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ampC Beta-lactamase AmpC (62480 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 424.86Molecular Weight (Monoisotopic): 424.0496AlogP: 1.18#Rotatable Bonds: 6
Polar Surface Area: 113.01Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.41CX Basic pKa: CX LogP: 0.71CX LogD: -2.69
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -0.04

References

1. Evans LE, Krishna A, Ma Y, Webb TE, Marshall DC, Tooke CL, Spencer J, Clarke TB, Armstrong A, Edwards AM..  (2019)  Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.,  62  (9): [PMID:31009558] [10.1021/acs.jmedchem.8b01923]

Source